Metabolon Acquires Cogenics Icoria’s Issued and Pending Metabolomics IP | GenomeWeb
NEW YORK (GenomeWeb News) ― Metabolon said yesterday it has acquired metabolomics-related intellectual property from Cogenics Icoria, a Clinical Data subsidiary, for an undisclosed sum.
 
Research Triangle Park, NC-based Metabolon said it now possesses all of the metabolomics-related IP that Cogenics Icoria previously owned.
 
Clinical Data acquired Cogenics Icoria in 2005.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.